ENTITY
Oyo

Oyo (1698548D IN)

53
Analysis
Real Estate • India
N/A
more
bullish•Concord Biotech
•17 Aug 2023 13:19

Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note

Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.

Logo
607 Views
Share
bullish•Concord Biotech
•04 Aug 2023 10:43

Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins

Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...

Logo
1.1k Views
Share
bullish•Concord Biotech
•02 Aug 2023 14:49

Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated

Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. Concord is an India-based biopharma firm, which develops and...

Logo
600 Views
Share
bullish•Concord Biotech
•30 Jan 2023 11:03

Concord Biotech Pre-IPO - Sales Have Been Growing but Watch Out for Its High Concentration Risk

Concord Biotech Ltd (658823Z IN) is looking to raise around US$250m in its upcoming India IPO. Concord is an India-based biopharma firm, which...

Logo
576 Views
Share
•19 Jan 2023 14:21

Avalon Technologies Pre-IPO - Sales Concentrated on a Handful. Market Tailwind Could Be Overstated

Avalon Technologies (6594468Z IN) is looking to raise about US$130m in its upcoming India IPO. The IPO is expected to consist of both a fresh issue...

Logo
562 Views
Share
x